Medical Science Liaison - Diagnostic (East)

Menarini Group•New York, NY

75d•$208,000 - $245,000•Onsite

About The Position

The Diagnostic Medical Science Liaison (MSL) is a field-based scientific expert responsible for advancing high-quality biomarker testing, diagnostic excellence, and precision-medicine readiness across oncology practices and laboratories. This role strengthens scientific partnerships with healthcare providers, pathologists, and laboratory leaders to ensure patients receive timely, guideline-aligned diagnostic testing that informs optimal therapeutic decisions. The Diagnostic MSL plays a critical role in shaping the diagnostic ecosystem by generating insights, educating stakeholders, and driving measurable improvements in testing adoption and patient identification.

Requirements

Advanced scientific degree (PhD, PharmD or MD preferred).
Minimum 3 years prior MSL, diagnostic liaison, or laboratory experience strongly preferred.
Deep understanding of oncology biomarkers, molecular diagnostics, and precision medicine.
Ability to synthesize complex scientific information and communicate clearly with diverse stakeholders.
Strong strategic thinking, relationship-building, and cross-functional collaboration skills.
Proven ability to work independently, as well as cross-functionally with numerous internal stakeholders in a high-matrixed environment, including joint venture collaborations
Excellent interpersonal communication and presentation skills, strong personal integrity, teamwork abilities, and a customer focus are necessary.
Must be able to organize, prioritize, and work effectively in a constantly changing environment.
Strong compliance knowledge and adherence to corporate compliance policies
Current working knowledge of FDA, OIG, ICH, GCP, PhRMA Code, HIPAA and other compliance regulations and guidelines relevant to industry interactions with healthcare professionals
Demonstrated technical acumen including MS Office skills, ability to adopt and leverage multiple business applications.

Nice To Haves

Deep understanding of oncology biomarkers, molecular diagnostics, and precision-medicine principles.
Ability to interpret complex diagnostic data, assay methodologies, and clinical evidence.
Maintains up-to-date knowledge of evolving standards of care, guideline updates, and diagnostic innovations.
Expertise in laboratory workflows, pre-analytic variables, assay validation, and quality considerations.
Understanding of diagnostic access barriers, ordering pathways, and operational constraints across diverse practice settings.
Ability to translate laboratory processes into actionable insights for clinicians and internal stakeholders.
Skilled at delivering clear, balanced, and tailored scientific education to diverse audiences, including oncologists, pathologists, and laboratory directors.
Ability to simplify complex diagnostic concepts while maintaining scientific rigor.
Strong presentation, facilitation, and scientific storytelling capabilities.
Identifies emerging diagnostic trends, unmet needs, and barriers to testing.
Synthesizes field insights into actionable recommendations that influence medical strategy.
Demonstrates strategic foresight in anticipating shifts in the diagnostic landscape.
Builds strong, trust-based peer-to-peer scientific relationships with EEs, emerging experts, laboratory leaders, and multidisciplinary care teams.
Navigates complex stakeholder environments with professionalism and scientific credibility.
Demonstrates influence without authority to drive diagnostic excellence.
Works effectively with Medical Affairs, Clinical Development, Market Access, HEOR, and Commercial (within compliance boundaries).
Provides diagnostic expertise to support internal training, strategy development, and evidence-generation initiatives.
Acts as a bridge between field insights and internal decision-making.
Utilizes strategic thinking skills and leverages technical expertise and landscape knowledge to deliver measurable impact on biomarker testing adoption, time-to-test, and patient identification.
Connects scientific engagement to improvements across the diagnostic-to-treatment continuum.
Uses data and insights to prioritize activities that drive meaningful patient and organizational outcomes.
Models integrity and adherence to all regulatory, legal, and compliance standards.
Ensures scientific interactions remain non-promotional and aligned with Medical Affairs governance.
Maintains patient-centricity and scientific objectivity in all engagements.
Thrives in a rapidly evolving diagnostic and therapeutic environment.
Demonstrates resilience, curiosity, and a commitment to ongoing scientific development.
Adapts communication and engagement strategies to diverse stakeholders and changing field dynamics.

Responsibilities

Build and maintain peer to peer scientific and clinical relationships with national and regional external experts (EEs) and academic laboratories to support appropriate adoption of biomarker testing.
Leverages technical expertise and landscape knowledge to identify relevant EEs and emerging experts for inclusion in territory plan.
Provide scientific education on testing methodologies, assay selection, turnaround time expectations, and interpretation of biomarker results relevant to therapeutic decision-making.
Support healthcare providers in understanding diagnostic pathways and barriers to testing, including pre-analytic variables, ordering workflows, and operational considerations.
Collaborate with laboratory stakeholders to help bring innovative, guideline-aligned diagnostic testing into routine oncology practice.
Gather, synthesize, and communicate actionable field insights related to testing practices, diagnostic workflows, treatment pathways, and the evolving biomarker landscape.
Identify emerging trends, scientific gaps, and barriers to biomarker testing, escalating clear and timely recommendations to Medical Affairs leadership.
Inform medical strategy, scientific education, and evidence-generation priorities through high-quality territory intelligence and real-world diagnostic insights.
Contribute to measurable improvements in biomarker testing adoption, time-to-test, and appropriate patient identification within the assigned territory.
Translate scientific engagement into improvements across the end-to-end patient journey—from testing to diagnosis to treatment initiation.
Demonstrate influence on testing practices and scientific understanding aligned with evolving standards of care in priority oncology indications.
Actively support and represent Stemline at national, regional and local scientific congresses in alignment with goals and objectives
Executes in line with annual goals and objectives expectations, and compliantly documents field activity, insights and expenses.